Neurocardiogenic Syncope
📧 Sign up to get email alerts when something new happens for Neurocardiogenic Syncope.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Autonomic Monitoring in Neurocardiogenic Syncope
Clinical trial 'Autonomic Monitoring in Neurocardiogenic Syncope' has completed, with the study status now listed as COMPLETED.
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: VINCI-AD: An Investigation of Transcutaneous Vagus Nerve Stimulation in Mild Cognitive Impairment. [NA]
VINCI-AD, a trial evaluating transcutaneous vagus nerve stimulation in mild cognitive impairment, has completed. The study lists mild cognit…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects
A completed clinical trial evaluating tilt-table testing in subjects with suspected postural orthostatic tachycardia syndrome (POTS) and rel…
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Cardioneuroablation for Neurocardiogenic Syncope [NA]
Clinical trial update indicates completion of the Cardioneuroablation trial for Neurocardiogenic Syncope, with results posted in November 20…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance [Phase 4]
A Phase 4 trial evaluating propranolol for neurocardiogenic syncope (fainting from sympathoadrenal imbalance) has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.